Skip to main content
VCbacked
Log inGet Started

Pheon Therapeutics

London, United Kingdom

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

$120.0M raised
May 2024
Series B
BiotechnologyLife ScienceMedicalTherapeutics

Top Investors

Lightspeed Venture PartnersBrandon CapitalPerceptive AdvisorsAtlas VentureForbion Capital Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Pheon Therapeutics

How much funding has Pheon Therapeutics raised?
Pheon Therapeutics has raised $120.0M in total funding. The most recent round was Series B. The last funding was announced in May 2024.
Who are Pheon Therapeutics's investors?
Pheon Therapeutics's investors include Lightspeed Venture Partners, Brandon Capital, Perceptive Advisors, Atlas Venture, Forbion Capital Partners.
Where is Pheon Therapeutics headquartered?
Pheon Therapeutics is headquartered in London, United Kingdom.
What does Pheon Therapeutics do?
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.
What stage is Pheon Therapeutics at?
Pheon Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Pheon Therapeutics — Funding & Investors." VCBacked, May 21, 2024, https://www.vcbacked.co/company/pheon-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Pheon Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/pheon-therapeutics
Wikipedia (cite web)
{{cite web |title=Pheon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pheon-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong